Observational studyDiabetes care2020
Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
Observational study in Diabetes care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.
- Stress hyperglycemia ratio in coronary artery disease: a systematic review and meta-analysis of severity and prognosis.Cardiovascular diabetology · 2026Pooled it
- Within-Person and Between-Sensor Variability in Continuous Glucose Monitoring Metrics.Clinical chemistry · 2023Trial
- Correlation Between Glycemic Biomarkers and Continuous Glucose Monitoring Metrics in Chronic Kidney Disease: A Systematic Review and Correlation Meta-Analysis.Journal of clinical medicine · 2026Review
- Advantages of Continuous and Non-Invasive Glucose Monitoring in the Geriatric Population: A Systematic Review.Journal of clinical medicine · 2026Review
- Article
- Application and management of continuous glucose monitoring in diabetic kidney disease.World journal of diabetes · 2024Article
- Impact of stress hyperglycemia ratio, derived from glycated albumin or hemoglobin A1c, on mortality among ST-segment elevation myocardial infarction patients.Cardiovascular diabetology · 2023Article
- Glycated Albumin Correlates With Time-in-Range Better Than HbA1c or Fructosamine.The Journal of clinical endocrinology and metabolism · 2023Article
- Glycated serum proteins and albumin but not glycated albumin show negative correlation with BMI in an overweight/obese, diabetic population from the United States.Clinical biochemistry · 2023Article
- Usefulness of continuous glucose monitoring of blood glucose control in patients with diabetes undergoing hemodialysis: A pilot study.Frontiers in medicine · 2023Article
- Diabetes Management and Outcomes among Patients with Type 2 Diabetes Attending a Renal Service.Journal of diabetes research · 2023Article
- Editorial: Technologies for diabetes.Frontiers in endocrinology · 2023Article
- The Need to Pair Molecular Monitoring Devices with Molecular Imaging to Personalize Health.Molecular imaging and biology · 2022Review
- Continuous Glucose Monitoring Metrics in the Assessment of Glycemia in Moderate-to-Advanced CKD in Diabetes.Kidney international reports · 2022Article
- Assessment of glycemia in chronic kidney disease.BMC medicine · 2022Review
- Use of Continuous Glucose Monitoring in the Assessment and Management of Patients With Diabetes and Chronic Kidney Disease.Frontiers in endocrinology · 2022Review
- Making sense of glucose sensors in end-stage kidney disease: A review.Frontiers in clinical diabetes and healthcare · 2022Review
- Use of continuous glucose monitoring system in patients with type 2 mellitus diabetic during hemodialysis treatment.Diabetology & metabolic syndrome · 2021Article
- Evaluation of Serum Glucose and Kidney Disease Progression Among Patients With Diabetes.JAMA network open · 2021Article
- Management of type 2 diabetes in chronic kidney disease.BMJ open diabetes research & care · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 1 country.
Funding
Abstract
objectiveIn chronic kidney disease, glycated albumin and fructosamine have been postulated to be better biomarkers of glycemic control than HbA RESEARCH DESIGN AND
methodsA prospective cohort study was conducted of 104 participants with type 2 diabetes, 80 with eGFR <60 mL/min/1.73 m
resultsWithin-person biomarker values were strongly correlated between the two CGM periods (
conclusionsGlycated albumin and fructosamine were not less variable than HbA
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.